Here are four things to know about the company’s stock:
1. Bacterin’s stock has a one-year low of $2.19 and a one-year high of $8.10.
2. The stock’s 50-day moving average is $4 and its 200-day moving average is $3.
3. The company’s market cap is $28.4 million.
4. In early April, Bacterin announced that its stock will be trading on the OTCQX marketplace after the New York Stock Exchange suspended trading the company’s common stock.
More articles on devices:
Clinical trials, team growth, IPO — 8 key notes on Bone Therapeutics’ 2014
Implanet Q1 revenue drops 21%, Spine up 77%: 10 key notes
Boston Scientific, Brainlab enter strategic collaboration — 5 key takeaways
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
